ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
97,826.25
-0.39%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Panacea Acquisition Corp (NUVB)

  7. Panacea Acquisition Corp (NUVB) News

NUVB

Panacea Acquisition (NUVB)

Panacea Acquisition Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NUVB
DateTimeSourceHeadlineSymbolCompany
12/23/20248:00AMBusiness WireU.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung CancerNYSE:NUVBPanacea Acquisition Corp
12/20/20247:10AMPR Newswire (US)Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products AdministrationNYSE:NUVBPanacea Acquisition Corp
11/26/20248:00AMBusiness WireNuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx ConferenceNYSE:NUVBPanacea Acquisition Corp
11/13/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
11/12/20244:05PMBusiness WireNuvation Bio to Present at the Jefferies London Healthcare ConferenceNYSE:NUVBPanacea Acquisition Corp
11/06/20244:43PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
11/06/20244:41PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NUVBPanacea Acquisition Corp
11/06/20244:05PMBusiness WireNuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
10/10/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
10/09/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
10/09/20244:09PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
10/07/20244:05PMBusiness WireNuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial OfficerNYSE:NUVBPanacea Acquisition Corp
09/14/20243:05AMBusiness WirePositive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024NYSE:NUVBPanacea Acquisition Corp
09/09/20248:00AMBusiness WireNuvation Bio to Present at the Cantor Global Healthcare ConferenceNYSE:NUVBPanacea Acquisition Corp
09/05/20244:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
09/05/20244:35PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
08/16/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:NUVBPanacea Acquisition Corp
08/15/20244:46PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:NUVBPanacea Acquisition Corp
08/13/20244:02PMEdgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNYSE:NUVBPanacea Acquisition Corp
08/05/20244:58PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:NUVBPanacea Acquisition Corp
08/05/20248:44AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NUVBPanacea Acquisition Corp
08/05/20248:37AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
08/05/20248:00AMBusiness WireNuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
07/30/20244:13PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:NUVBPanacea Acquisition Corp
07/30/20244:01PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNYSE:NUVBPanacea Acquisition Corp
07/23/20244:05PMBusiness WireNuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, TaletrectinibNYSE:NUVBPanacea Acquisition Corp
07/16/20249:03AMEdgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNYSE:NUVBPanacea Acquisition Corp
06/01/20248:10AMBusiness WireNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual MeetingNYSE:NUVBPanacea Acquisition Corp
05/29/20244:05PMBusiness WireNuvation Bio to Present at the Jefferies Global Healthcare ConferenceNYSE:NUVBPanacea Acquisition Corp
05/24/20245:22PMEdgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNYSE:NUVBPanacea Acquisition Corp
 Showing the most relevant articles for your search:NYSE:NUVB

Your Recent History

USOTC
GDVM
Global Developments (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
TWOH
Two Hands (PK)
USOTC
AFFU
Affluence (PK)
COIN
XRPUSD
Ripple
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RNVA
Rennova Health (CE)
NASDAQ
AMRN
Amarin
USOTC
RDGL
Vivos (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
TSLA
Tesla
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
LWLG
Lightwave Logic
USOTC
HMBL
HUMBL (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
AABB
Asia Broadband (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads